New Points of Departure for More Global Influenza Vaccine Use

New Points of Departure for More Global Influenza Vaccine Use

Each year, influenza causes a significant acute respiratory disease burden. In addition, influenza pandemics periodically occur. Annual vaccination is the best tool for influenza prevention, but its effectiveness can vary from year to year. The narrow specificity of conventional vaccines and the dru...

Full description

Bibliographic Details
Main Author: Irina Kiseleva
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Vaccines
Subjects:
influenza
inactivated vaccines
live attenuated vaccines
next-generation vaccines
synthetic vaccines
cross protectivity
Online Access:https://www.mdpi.com/2076-393X/8/3/410
Description
Summary:Each year, influenza causes a significant acute respiratory disease burden. In addition, influenza pandemics periodically occur. Annual vaccination is the best tool for influenza prevention, but its effectiveness can vary from year to year. The narrow specificity of conventional vaccines and the drug resistance of currently circulating viruses reduce the effectiveness of prophylaxis and treatment and require the development of new broad-spectrum preparations. Furthermore, the challenge of creating a highly effective universal influenza vaccine takes on renewed intensity in the face of the COVID-19 pandemic.
ISSN:2076-393X

Similar Items